Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dancey

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
Targeted therapies and clinical trials in ovarian cancerJ Dancey
The Canadian Journal of Hospital Pharmacy|February 11, 1977
Building on the basicsJ Dancey
The Canadian Journal of Hospital Pharmacy|December 13, 1976
The President's viewpoint: monitoring the geriatric patient's drug therapy--a challenge to hospital pharmacyJ Dancey
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
Impact of new non-cytotoxics in the treatment of ovarian cancerE Eisenhauer, J Dancey
Anti-Cancer Drugs|October 1, 1995
The role of vindesine in oncology--recommendations after 10 years' experienceJ Dancey, W P Steward
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 22, 1999
Skeletal muscle energy metabolism during prolonged, fatiguing exerciseM A Febbraio, J Dancey
British Journal of Cancer|August 1, 1996
Current perspectives on camptothecins in cancer treatmentJ Dancey, E A Eisenhauer
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Non-small cell lung cancer: an overview of current managementJ Dancey, T Le Chevalier
Canadian Medical Association Journal|July 9, 1977
Spurious results of Schilling Tests with Frosst intrinsic factorM Katz, M Vas, J Dancey
Journal of Biopharmaceutical Statistics|June 24, 1999
Multinomial phase II cancer trials incorporating response and early progressionB Zee, D Melnychuk, J Dancey, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
Targeted therapies and clinical trials in ovarian cancerJ Dancey
The Canadian Journal of Hospital Pharmacy|February 11, 1977
Building on the basicsJ Dancey
The Canadian Journal of Hospital Pharmacy|December 13, 1976
The President's viewpoint: monitoring the geriatric patient's drug therapy--a challenge to hospital pharmacyJ Dancey
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2001
Impact of new non-cytotoxics in the treatment of ovarian cancerE Eisenhauer, J Dancey
Anti-Cancer Drugs|October 1, 1995
The role of vindesine in oncology--recommendations after 10 years' experienceJ Dancey, W P Steward
Journal of Applied Physiology (Bethesda, Md. : 1985)|December 22, 1999
Skeletal muscle energy metabolism during prolonged, fatiguing exerciseM A Febbraio, J Dancey
British Journal of Cancer|August 1, 1996
Current perspectives on camptothecins in cancer treatmentJ Dancey, E A Eisenhauer
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Non-small cell lung cancer: an overview of current managementJ Dancey, T Le Chevalier
Canadian Medical Association Journal|July 9, 1977
Spurious results of Schilling Tests with Frosst intrinsic factorM Katz, M Vas, J Dancey
Journal of Biopharmaceutical Statistics|June 24, 1999
Multinomial phase II cancer trials incorporating response and early progressionB Zee, D Melnychuk, J Dancey, et al.
Pageof 4